Communiqués Odyssey Health, Inc.

Actions

ODYY

US67612C1027

Marché Fermé - OTC Markets Autres places de cotation 21:15:28 06/06/2024			Varia. 5j.	Varia. 1 janv.
0,028 ^USD	-9,52%		-20,85%	-71,90%

22/03	Odyssey Health, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 janvier 2024	CI
2023	Oragenics, Inc. (NYSEAM:OGEN) a finalisé l'acquisition des actifs liés aux thérapies et technologies de médicaments neurologiques propriétaires d'Odyssey Health, Inc.	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Oragenics to Acquire Odyssey Health's Neurological Drug Technology Pipeline Including Concussion Drug Candidate	06/10/23	AQ
AM Best Upgrades Credit Ratings of Odyssey Group Holdings, Inc.'s Members	07/07/23	AQ
ODYSSEY HEALTH, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	04/04/23	AQ
Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment	30/03/23	AQ
ODYSSEY HEALTH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	17/03/23	AQ
Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research	07/02/23	AQ
ODYSSEY HEALTH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	13/01/23	AQ
Odyssey Health, Inc. To Develop Intranasal Field- Deliverable Nerve Agent Antidote	12/01/23	AQ
ODYSSEY HEALTH, INC. : Change in Directors or Principal Officers (form 8-K)	06/01/23	AQ
ODYSSEY HEALTH, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	03/01/23	AQ
Odyssey Health, Inc. Provides a Year End Update on Company and Corporate Outlook for 2023	19/12/22	AQ
ODYSSEY HEALTH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/12/22	AQ
ODYSSEY HEALTH, INC. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	25/11/22	AQ
ODYSSEY HEALTH, INC. : Other Events (form 8-K)	23/11/22	AQ
ODYSSEY HEALTH, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	23/11/22	AQ
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development	23/11/22	AQ
Odyssey Health, Inc. Schedules Annual Meeting of Stockholders	15/11/22	AQ
ODYSSEY HEALTH, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	04/11/22	AQ
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team	03/11/22	AQ
ODYSSEY HEALTH, INC. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	01/11/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Odyssey Health, Inc.

Actions

ODYY

US67612C1027

Communiqués

Filtres